Skip to main content
Top
Published in: Endocrine 3/2018

01-12-2018 | Review

Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions

Authors: Ulla Feldt-Rasmussen, Marianne Klose, Salvatore Benvenga

Published in: Endocrine | Issue 3/2018

Login to get access

Abstract

Central hypothyroidism is defined as low circulating free thyroxine (free T4) with inappropriately low circulating thyrotropin (TSH), in context of a hypothalamic pituitary pathology. Rare cases of idiopathic central hypothyroidism caused by a functional defect may occur, and the condition is often overlooked due to difficulty in achieving the correct diagnosis, sparse symptomatology of the condition and a high risk of misinterpretion of the biochemical changes in central hypothyroidism. Central hypothyroidism is mainly seen in patients with hypothalamic–pituitary pathology due to one of many possible aetiologies, where other hormone deficiencies often co-exist, and both the presence of other deficiencies and their replacement have a strong influence on the measurement of the thyroid-related hormones and thereby interpretation of the thyroid function variables in relation to the clinical impact of thyroid hormone substitution therapy. Conversely, lack of thyroid hormone has a similar strong influence on the interpretation of other pituitary hormone axes, as well as their replacement. Undertreating patients with central hypothyroidism may have serious metabolic consequences with a potentially increased risk of cardiovascular morbidity. The present review thus aims at describing central hypothyroidism, by an overview of interactions of hypothyroidism with other pituitary hormones, diagnosing/testing for central hypothyroidism, and focusing on consequences of undertreatment. Finally, it is mentioned how to deal with new diagnostic settings with lower a priori likelihood of hypopituitarism, particularly in view of the importance of stringent diagnostic testing in order to avoid overdiagnosing central hypothyroidism.
Literature
1.
go back to reference L. Persani, P. Beck-Peccoz Central Hypothyroidism. In: L. Braverman, D. Cooper, (eds.) Werners & Ingbar's The thyroid. A clinical and fundamental text. 10th ed. Philadelphia: Wolters Kluwer, Lippincott Williams & Wilkins, 2013; 560–568. L. Persani, P. Beck-Peccoz Central Hypothyroidism. In: L. Braverman, D. Cooper, (eds.) Werners & Ingbar's The thyroid. A clinical and fundamental text. 10th ed. Philadelphia: Wolters Kluwer, Lippincott Williams & Wilkins, 2013; 560–568.
2.
go back to reference U. Feldt-Rasmussen, M. Klose, Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients. Endocrine 54, 15–23 (2016)CrossRef U. Feldt-Rasmussen, M. Klose, Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients. Endocrine 54, 15–23 (2016)CrossRef
3.
go back to reference L. Persani, Clinical review: central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J. Clin. Endocrinol. Metab. 97, 3068–3078 (2012)CrossRef L. Persani, Clinical review: central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J. Clin. Endocrinol. Metab. 97, 3068–3078 (2012)CrossRef
4.
go back to reference Z. Baloch, P. Carayon, B. Conte-Devolx, L.M. Demers, U. Feldt-Rasmussen, J.F. Henry, V.A. LiVosli, P. Niccoli-Sire, R. John, J. Ruf, P.P. Smyth, C.A. Spencer, J.R. Stockigt, Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13, 3–126 (2003)CrossRef Z. Baloch, P. Carayon, B. Conte-Devolx, L.M. Demers, U. Feldt-Rasmussen, J.F. Henry, V.A. LiVosli, P. Niccoli-Sire, R. John, J. Ruf, P.P. Smyth, C.A. Spencer, J.R. Stockigt, Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13, 3–126 (2003)CrossRef
5.
go back to reference J.R. Stockigt, in Endotext, https://www.ncbi.nlm.nih.gov/books/NBK285558/ (2011). Accessed February 2018 J.R. Stockigt, in Endotext, https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK285558/​ (2011). Accessed February 2018
6.
go back to reference H. Zulewski, B. Muller, P. Exer, A.R. Miserez, J.J. Staub, Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J. Clin. Endocrinol. Metab. 82, 771–776 (1997)PubMed H. Zulewski, B. Muller, P. Exer, A.R. Miserez, J.J. Staub, Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J. Clin. Endocrinol. Metab. 82, 771–776 (1997)PubMed
7.
go back to reference M.S. Seshadri, B.U. Samuel, A.S. Kanagasabapathy, A.M. Cherian, Clinical scoring system for hypothyroidism: is it useful? J. Gen. Intern. Med. 4, 490–492 (1989)CrossRef M.S. Seshadri, B.U. Samuel, A.S. Kanagasabapathy, A.M. Cherian, Clinical scoring system for hypothyroidism: is it useful? J. Gen. Intern. Med. 4, 490–492 (1989)CrossRef
8.
go back to reference G. Van den Berghe, Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid 24, 1456–1465 (2014)CrossRef G. Van den Berghe, Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid 24, 1456–1465 (2014)CrossRef
9.
go back to reference A. Waise, P.E. Belchetz, Lesson of the week: unsuspected central hypothyroidism. BMJ 321, 1275–1277 (2000)CrossRef A. Waise, P.E. Belchetz, Lesson of the week: unsuspected central hypothyroidism. BMJ 321, 1275–1277 (2000)CrossRef
10.
go back to reference P. Beck-Peccoz, G. Rodari, C. Giavoli, A. Lania, Central hypothyroidism - a neglected thyroid disorder. Nat. Rev. Endocrinol. 13, 588–598 (2017)CrossRef P. Beck-Peccoz, G. Rodari, C. Giavoli, A. Lania, Central hypothyroidism - a neglected thyroid disorder. Nat. Rev. Endocrinol. 13, 588–598 (2017)CrossRef
11.
go back to reference S. Benvenga, M. Klose, R. Vita, U. Feldt-Rasmussen, Less known aspects of central hypothyroidism: part 1 - aquired etiologies. J. Clin. Transl. Endocrinol. (2018) (in press) S. Benvenga, M. Klose, R. Vita, U. Feldt-Rasmussen, Less known aspects of central hypothyroidism: part 1 - aquired etiologies. J. Clin. Transl. Endocrinol. (2018) (in press)
12.
go back to reference U. Feldt-Rasmussen, Interactions between growth hormone and the thyroid gland -- with special reference to biochemical diagnosis. Curr. Med. Chem. 14, 2783–2788 (2007)CrossRef U. Feldt-Rasmussen, Interactions between growth hormone and the thyroid gland -- with special reference to biochemical diagnosis. Curr. Med. Chem. 14, 2783–2788 (2007)CrossRef
13.
go back to reference H. Filipsson, G. Johannsson, GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies. Eur. J. Endocrinol. 161 Suppl 1, S85–S95 (2009)CrossRef H. Filipsson, G. Johannsson, GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies. Eur. J. Endocrinol. 161 Suppl 1, S85–S95 (2009)CrossRef
14.
go back to reference M. Klose, D. Marina, M.L. Hartoft-Nielsen, O. Klefter, V. Gavan, L. Hilsted, A.K. Rasmussen, U. Feldt-Rasmussen, Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients. J. Clin. Endocrinol. Metab. 98, 3802–3810 (2013)CrossRef M. Klose, D. Marina, M.L. Hartoft-Nielsen, O. Klefter, V. Gavan, L. Hilsted, A.K. Rasmussen, U. Feldt-Rasmussen, Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients. J. Clin. Endocrinol. Metab. 98, 3802–3810 (2013)CrossRef
15.
go back to reference N.H. Filipsson, U. Feldt-Rasmussen, I. Kourides, V. Popovic, M. Koltowska-Haggstrom, B. Jonsson, G. Johannsson, The metabolic consequences of thyroxine replacement in adult hypopituitary patients. Pituitary 15, 495–504 (2012)CrossRef N.H. Filipsson, U. Feldt-Rasmussen, I. Kourides, V. Popovic, M. Koltowska-Haggstrom, B. Jonsson, G. Johannsson, The metabolic consequences of thyroxine replacement in adult hypopituitary patients. Pituitary 15, 495–504 (2012)CrossRef
16.
go back to reference L. Persani, G. Brabant, D. Dattani, M. Bonomi, U. Feldt-Rasmussen, E. Fliers, A. Gruters, D. Maiter, N. Schoenmakers, A.S. Trotsenburg, 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism. Eur. Thyroid J. e-pub ahead of print. https://doi.org/10.1159/000491388 (2018)CrossRef L. Persani, G. Brabant, D. Dattani, M. Bonomi, U. Feldt-Rasmussen, E. Fliers, A. Gruters, D. Maiter, N. Schoenmakers, A.S. Trotsenburg, 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism. Eur. Thyroid J. e-pub ahead of print. https://​doi.​org/​10.​1159/​000491388 (2018)CrossRef
17.
go back to reference S. Grunenwald, P. Caron, Central hypothyroidism in adults: better understanding for better care. Pituitary 18, 169–175 (2015)CrossRef S. Grunenwald, P. Caron, Central hypothyroidism in adults: better understanding for better care. Pituitary 18, 169–175 (2015)CrossRef
18.
go back to reference M. Schmiegelow, U. Feldt-Rasmussen, A.K. Rasmussen, H.S. Poulsen, J. Muller, A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. J. Clin. Endocrinol. Metab. 88, 136–140 (2003)CrossRef M. Schmiegelow, U. Feldt-Rasmussen, A.K. Rasmussen, H.S. Poulsen, J. Muller, A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. J. Clin. Endocrinol. Metab. 88, 136–140 (2003)CrossRef
19.
go back to reference A. Lando, K. Holm, K. Nysom, A.K. Rasmussen, U. Feldt-Rasmussen, J.H. Petersen, J. Muller, Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation. Clin. Endocrinol. 55, 21–25 (2001)CrossRef A. Lando, K. Holm, K. Nysom, A.K. Rasmussen, U. Feldt-Rasmussen, J.H. Petersen, J. Muller, Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation. Clin. Endocrinol. 55, 21–25 (2001)CrossRef
20.
go back to reference A. Saha, C.G. Salley, P. Saigal, L. Rolnitzky, J. Goldberg, S. Scott, R. Olshefski, J. Hukin, S.A. Sands, J. Finlay, S.L. Gardner, Late effects in survivors of childhood CNS tumors treated on head start I and II protocols. Pediatr. Blood Cancer 61, 1644–1652 (2014)CrossRef A. Saha, C.G. Salley, P. Saigal, L. Rolnitzky, J. Goldberg, S. Scott, R. Olshefski, J. Hukin, S.A. Sands, J. Finlay, S.L. Gardner, Late effects in survivors of childhood CNS tumors treated on head start I and II protocols. Pediatr. Blood Cancer 61, 1644–1652 (2014)CrossRef
21.
go back to reference J.G. Gurney, N.S. Kadan-Lottick, R.J. Packer, J.P. Neglia, C.A. Sklar, J.A. Punyko, M. Stovall, Y. Yasui, H.S. Nicholson, S. Wolden, D.E. McNeil, A.C. Mertens, L.L. Robison, Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 97, 663–673 (2003)CrossRef J.G. Gurney, N.S. Kadan-Lottick, R.J. Packer, J.P. Neglia, C.A. Sklar, J.A. Punyko, M. Stovall, Y. Yasui, H.S. Nicholson, S. Wolden, D.E. McNeil, A.C. Mertens, L.L. Robison, Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 97, 663–673 (2003)CrossRef
22.
go back to reference A. Garrahy, M. Sherlock, C.J. Thompson, Management of endocrine disease: neuroendocrine surveillance and management of neurosurgical patients. Eur. J. Endocrinol. 176, R217–R233 (2017)CrossRef A. Garrahy, M. Sherlock, C.J. Thompson, Management of endocrine disease: neuroendocrine surveillance and management of neurosurgical patients. Eur. J. Endocrinol. 176, R217–R233 (2017)CrossRef
23.
go back to reference M. Klose, U. Feldt-Rasmussen, Chronic endocrine consequences of traumatic brain injury - what is the evidence? Nat. Rev. Endocrinol. 14, 57–62 (2018)CrossRef M. Klose, U. Feldt-Rasmussen, Chronic endocrine consequences of traumatic brain injury - what is the evidence? Nat. Rev. Endocrinol. 14, 57–62 (2018)CrossRef
24.
go back to reference S. Roug, A.K. Rasmussen, M. Juhler, M. Kosteljanetz, L. Poulsgaard, H. Heeboll, H. Roed, U. Feldt-Rasmussen, Fractionated stereotactic radiotherapy in patients with acromegaly: an interim single-centre audit. Eur. J. Endocrinol. 162, 685–694 (2010)CrossRef S. Roug, A.K. Rasmussen, M. Juhler, M. Kosteljanetz, L. Poulsgaard, H. Heeboll, H. Roed, U. Feldt-Rasmussen, Fractionated stereotactic radiotherapy in patients with acromegaly: an interim single-centre audit. Eur. J. Endocrinol. 162, 685–694 (2010)CrossRef
25.
go back to reference A. Astradsson, P. Munck Af Rosenschöld, U. Feldt-Rasmussen, L. Poulsgaard, A.K. Wiencke, L. Ohlhues, S.A. Engelholm, H. Broholm, M.E. Hansen, M. Klose, H. Roed, M. Juhler, Visual outcome, endocrine function and tumor control after fractionated stereotactic radiation therapy of craniopharyngiomas in adults: findings in a prospective cohort. Acta Oncol. 56, 415–421 (2017)CrossRef A. Astradsson, P. Munck Af Rosenschöld, U. Feldt-Rasmussen, L. Poulsgaard, A.K. Wiencke, L. Ohlhues, S.A. Engelholm, H. Broholm, M.E. Hansen, M. Klose, H. Roed, M. Juhler, Visual outcome, endocrine function and tumor control after fractionated stereotactic radiation therapy of craniopharyngiomas in adults: findings in a prospective cohort. Acta Oncol. 56, 415–421 (2017)CrossRef
26.
go back to reference P.J. Snyder, B.F. Fowble, N.J. Schatz, P.J. Savino, T.A. Gennarelli, Hypopituitarism following radiation therapy of pituitary adenomas. Am. J. Med. 81, 457–462 (1986)CrossRef P.J. Snyder, B.F. Fowble, N.J. Schatz, P.J. Savino, T.A. Gennarelli, Hypopituitarism following radiation therapy of pituitary adenomas. Am. J. Med. 81, 457–462 (1986)CrossRef
27.
go back to reference L.S. Constine, P.D. Woolf, D. Cann, G. Mick, K. McCormick, R.F. Raubertas, P. Rubin, Hypothalamic-pituitary dysfunction after radiation for brain tumors. N. Engl. J. Med. 328, 87–94 (1993)CrossRef L.S. Constine, P.D. Woolf, D. Cann, G. Mick, K. McCormick, R.F. Raubertas, P. Rubin, Hypothalamic-pituitary dysfunction after radiation for brain tumors. N. Engl. J. Med. 328, 87–94 (1993)CrossRef
28.
go back to reference N. Mathioudakis, S. Thapa, G.S. Wand, R. Salvatori, ACTH-secreting pituitary microadenomas are associated with a higher prevalence of central hypothyroidism compared to other microadenoma types. Clin. Endocrinol. 77, 871–876 (2012)CrossRef N. Mathioudakis, S. Thapa, G.S. Wand, R. Salvatori, ACTH-secreting pituitary microadenomas are associated with a higher prevalence of central hypothyroidism compared to other microadenoma types. Clin. Endocrinol. 77, 871–876 (2012)CrossRef
29.
go back to reference B.M. Arafah, Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab. 62, 1173–1179 (1986)CrossRef B.M. Arafah, Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab. 62, 1173–1179 (1986)CrossRef
30.
go back to reference U. Feldt-Rasmussen, M. Klose, in Endotext, https://www.ncbi.nlm.nih.gov/books/NBK425701/ (2017). Accessed February 2018 U. Feldt-Rasmussen, M. Klose, in Endotext, https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK425701/​ (2017). Accessed February 2018
31.
go back to reference B.R. Haugen, Drugs that suppress TSH or cause central hypothyroidism. Best. Pract. Res. Clin. Endocrinol. Metab. 23, 793–800 (2009)CrossRef B.R. Haugen, Drugs that suppress TSH or cause central hypothyroidism. Best. Pract. Res. Clin. Endocrinol. Metab. 23, 793–800 (2009)CrossRef
32.
go back to reference S.I. Sherman, J. Gopal, B.R. Haugen, A.C. Chiu, K. Whaley, P. Nowlakha, M. Duvic, Central hypothyroidism associated with retinoid X receptor-selective ligands. N. Engl. J. Med. 340, 1075–1079 (1999)CrossRef S.I. Sherman, J. Gopal, B.R. Haugen, A.C. Chiu, K. Whaley, P. Nowlakha, M. Duvic, Central hypothyroidism associated with retinoid X receptor-selective ligands. N. Engl. J. Med. 340, 1075–1079 (1999)CrossRef
33.
go back to reference J. Graeppi-Dulac, V. Vlaeminck-Guillem, M. Perier-Muzet, S. Dalle, J. Orgiazzi, Endocrine side-effects of anti-cancer drugs: The impact of retinoids on the thyroid axis. Eur. J. Endocrinol. 170, R253–R262 (2014)CrossRef J. Graeppi-Dulac, V. Vlaeminck-Guillem, M. Perier-Muzet, S. Dalle, J. Orgiazzi, Endocrine side-effects of anti-cancer drugs: The impact of retinoids on the thyroid axis. Eur. J. Endocrinol. 170, R253–R262 (2014)CrossRef
34.
go back to reference M.C. Zatelli, E. Gentilin, F. Daffara, F. Tagliati, G. Reimondo, G. Carandina, M.R. Ambrosio, M. Terzolo, E.C. Degli Uberti, Therapeutic concentrations of mitotane (o,p′-DDD) inhibit hyrotroph cell viability and TSH expression and secretion in a mouse cell line model. Endocrinology 151, 2453–2461 (2010)CrossRef M.C. Zatelli, E. Gentilin, F. Daffara, F. Tagliati, G. Reimondo, G. Carandina, M.R. Ambrosio, M. Terzolo, E.C. Degli Uberti, Therapeutic concentrations of mitotane (o,p′-DDD) inhibit hyrotroph cell viability and TSH expression and secretion in a mouse cell line model. Endocrinology 151, 2453–2461 (2010)CrossRef
35.
go back to reference M. Russo, C. Scollo, G. Pellegriti, O.R. Cotta, S. Squatrito, F. Frasca, S. Cannavo, D. Gullo, Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism. Clin. Endocrinol. 84, 614–19 (2015)CrossRef M. Russo, C. Scollo, G. Pellegriti, O.R. Cotta, S. Squatrito, F. Frasca, S. Cannavo, D. Gullo, Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism. Clin. Endocrinol. 84, 614–19 (2015)CrossRef
36.
go back to reference F. Torino, A. Barnabei, R.M. Paragliola, P. Marchetti, R. Salvatori, S.M. Corsello, Endocrine side-effects of anticancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. Eur. J. Endocrinol. 169, R153–R164 (2013)CrossRef F. Torino, A. Barnabei, R.M. Paragliola, P. Marchetti, R. Salvatori, S.M. Corsello, Endocrine side-effects of anticancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. Eur. J. Endocrinol. 169, R153–R164 (2013)CrossRef
37.
go back to reference M. Klose, K. Stochholm, J. Janukonyte, C.L. Lehman, J. Frystyk, M. Andersen, P. Laurberg, J.S. Christiansen, U. Feldt-Rasmussen, Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up: results from The Danish National Study on Posttraumatic Hypopituitarism. J. Clin. Endocrinol. Metab. 99, 101–110 (2014)CrossRef M. Klose, K. Stochholm, J. Janukonyte, C.L. Lehman, J. Frystyk, M. Andersen, P. Laurberg, J.S. Christiansen, U. Feldt-Rasmussen, Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up: results from The Danish National Study on Posttraumatic Hypopituitarism. J. Clin. Endocrinol. Metab. 99, 101–110 (2014)CrossRef
38.
go back to reference J.A. Romijn, J.W. Smit, S.W. Lamberts, Intrinsic imperfections of endocrine replacement therapy. Eur. J. Endocrinol. 149, 91–97 (2003)CrossRef J.A. Romijn, J.W. Smit, S.W. Lamberts, Intrinsic imperfections of endocrine replacement therapy. Eur. J. Endocrinol. 149, 91–97 (2003)CrossRef
39.
go back to reference A. Agha, D. Walker, L. Perry, W.M. Drake, S.L. Chew, P.J. Jenkins, A.B. Grossman, J.P. Monson, Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin. Endocrinol. 66, 72–77 (2007) A. Agha, D. Walker, L. Perry, W.M. Drake, S.L. Chew, P.J. Jenkins, A.B. Grossman, J.P. Monson, Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin. Endocrinol. 66, 72–77 (2007)
40.
go back to reference J.O. Jorgensen, J. Moller, T. Laursen, H. Orskov, J.S. Christiansen, J. Weeke, Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin. Endocrinol. 41, 609–614 (1994)CrossRef J.O. Jorgensen, J. Moller, T. Laursen, H. Orskov, J.S. Christiansen, J. Weeke, Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin. Endocrinol. 41, 609–614 (1994)CrossRef
41.
go back to reference J.O. Jorgensen, J. Moller, N.E. Skakkebaek, J. Weeke, J.S. Christiansen, Thyroid function during growth hormone therapy. Horm. Res. 38 Suppl 1, 63–67 (1992)PubMed J.O. Jorgensen, J. Moller, N.E. Skakkebaek, J. Weeke, J.S. Christiansen, Thyroid function during growth hormone therapy. Horm. Res. 38 Suppl 1, 63–67 (1992)PubMed
42.
go back to reference P. Laurberg, P.E. Jakobsen, H.C. Hoeck, P. Vestergaard, Growth hormone and thyroid function: is secondary thyroid failure underdiagnosed in growth hormone deficient patients? Thyroidology 6, 73–79 (1994)PubMed P. Laurberg, P.E. Jakobsen, H.C. Hoeck, P. Vestergaard, Growth hormone and thyroid function: is secondary thyroid failure underdiagnosed in growth hormone deficient patients? Thyroidology 6, 73–79 (1994)PubMed
43.
go back to reference A.A. Toogood, N.F. Taylor, S.M. Shalet, J.P. Monson, Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. J. Clin. Endocrinol. Metab. 85, 1727–1730 (2000)PubMed A.A. Toogood, N.F. Taylor, S.M. Shalet, J.P. Monson, Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. J. Clin. Endocrinol. Metab. 85, 1727–1730 (2000)PubMed
44.
go back to reference L.A. Behan, J.P. Monson, A. Agha, The interaction between growth hormone and the thyroid axis in hypopituitary patients. Clin. Endocrinol. 74, 281–288 (2011)CrossRef L.A. Behan, J.P. Monson, A. Agha, The interaction between growth hormone and the thyroid axis in hypopituitary patients. Clin. Endocrinol. 74, 281–288 (2011)CrossRef
45.
go back to reference C. Schmid, C. Zwimpfer, M. Brandle, P.A. Krayenbuhl, J. Zapf, P. Wiesli, Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism. Clin. Endocrinol. 65, 706–711 (2006)CrossRef C. Schmid, C. Zwimpfer, M. Brandle, P.A. Krayenbuhl, J. Zapf, P. Wiesli, Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism. Clin. Endocrinol. 65, 706–711 (2006)CrossRef
46.
go back to reference J.P. Span, G.F. Pieters, C.G. Sweep, A.R. Hermus, A.G. Smals, Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. J. Clin. Endocrinol. Metab. 85, 1121–1125 (2000)CrossRef J.P. Span, G.F. Pieters, C.G. Sweep, A.R. Hermus, A.G. Smals, Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. J. Clin. Endocrinol. Metab. 85, 1121–1125 (2000)CrossRef
47.
go back to reference T. Wolthers, D.M. Hoffman, A.G. Nugent, M.W. Duncan, M. Umpleby, K.K. Ho, Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am. J. Physiol. Endocrinol. Metab. 281, E1191–E1196 (2001)CrossRef T. Wolthers, D.M. Hoffman, A.G. Nugent, M.W. Duncan, M. Umpleby, K.K. Ho, Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am. J. Physiol. Endocrinol. Metab. 281, E1191–E1196 (2001)CrossRef
48.
go back to reference J.J. Christiansen, S. Fisker, C.H. Gravholt, P. Bennett, B. Svenstrup, M. Andersen, U. Feldt-Rasmussen, J.S. Christiansen, J.O. Jorgensen, Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I. Eur. J. Endocrinol. 152, 719–726 (2005)CrossRef J.J. Christiansen, S. Fisker, C.H. Gravholt, P. Bennett, B. Svenstrup, M. Andersen, U. Feldt-Rasmussen, J.S. Christiansen, J.O. Jorgensen, Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I. Eur. J. Endocrinol. 152, 719–726 (2005)CrossRef
49.
go back to reference A.J. Weissberger, K.K. Ho, L. Lazarus, Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24 hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J. Clin. Endocrinol. Metab. 72, 374–381 (1991)CrossRef A.J. Weissberger, K.K. Ho, L. Lazarus, Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24 hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J. Clin. Endocrinol. Metab. 72, 374–381 (1991)CrossRef
50.
go back to reference J.H. Oliveira, L. Persani, P. Beck-Peccoz, J. Abucham, Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan’s syndrome: characterization of TSH carbohydrate content and bioactivity. J. Clin. Endocrinol. Metab. 86, 1694–1699 (2001)PubMed J.H. Oliveira, L. Persani, P. Beck-Peccoz, J. Abucham, Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan’s syndrome: characterization of TSH carbohydrate content and bioactivity. J. Clin. Endocrinol. Metab. 86, 1694–1699 (2001)PubMed
51.
go back to reference N.H. Esfandiari, M. Papaleontiou, Biochemical testing in thyroid disorders. Endocrinol. Metab. Clin. North Am. 46, 631–648 (2017)CrossRef N.H. Esfandiari, M. Papaleontiou, Biochemical testing in thyroid disorders. Endocrinol. Metab. Clin. North Am. 46, 631–648 (2017)CrossRef
52.
go back to reference L.D. Premawardhana, Thyroid testing in acutely ill patients may be an expensive distraction. Biochem. Med. 27, 300–307 (2017)CrossRef L.D. Premawardhana, Thyroid testing in acutely ill patients may be an expensive distraction. Biochem. Med. 27, 300–307 (2017)CrossRef
53.
go back to reference S. Benvenga, S. Squadrito, F. Saporito, A. Cimino, F. Arrigo, F. Trimarchi, Myxedema coma of both primary and secondary origin, with non-classic presentation and extremely elevated creatine kinase. Horm. Metab. Res. 32, 364–366 (2000)CrossRef S. Benvenga, S. Squadrito, F. Saporito, A. Cimino, F. Arrigo, F. Trimarchi, Myxedema coma of both primary and secondary origin, with non-classic presentation and extremely elevated creatine kinase. Horm. Metab. Res. 32, 364–366 (2000)CrossRef
54.
go back to reference K. Iida, Y. Hino, T. Ohara, K. Chihara, A case of myxedema coma caused by isolated thyrotropin stimulating hormone deficiency and Hashimoto’s thyroiditis. Endocr. J. 58, 143–148 (2011)CrossRef K. Iida, Y. Hino, T. Ohara, K. Chihara, A case of myxedema coma caused by isolated thyrotropin stimulating hormone deficiency and Hashimoto’s thyroiditis. Endocr. J. 58, 143–148 (2011)CrossRef
55.
go back to reference U. Feldt-Rasmussen, P.P. Hyltoft, O. Blaabjerg, M. Horder, Long-term variability in serum thyroglobulin and thyroid related hormones in healthy subjects. Acta Endocrinol. 95, 328–334 (1980)CrossRef U. Feldt-Rasmussen, P.P. Hyltoft, O. Blaabjerg, M. Horder, Long-term variability in serum thyroglobulin and thyroid related hormones in healthy subjects. Acta Endocrinol. 95, 328–334 (1980)CrossRef
56.
go back to reference S. Andersen, K.M. Pedersen, N.H. Bruun, P. Laurberg, Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J. Clin. Endocrinol. Metab. 87, 1068–1072 (2002)CrossRef S. Andersen, K.M. Pedersen, N.H. Bruun, P. Laurberg, Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J. Clin. Endocrinol. Metab. 87, 1068–1072 (2002)CrossRef
57.
go back to reference K.J. Welsh, S.J. Soldin, Diagnosis of endocrine disease: how reliable are free thyroid and total T3 hormone assays? Eur. J. Endocrinol. 175, R255–R263 (2016)CrossRef K.J. Welsh, S.J. Soldin, Diagnosis of endocrine disease: how reliable are free thyroid and total T3 hormone assays? Eur. J. Endocrinol. 175, R255–R263 (2016)CrossRef
58.
go back to reference M.L. Hartoft-Nielsen, M. Lange, A.K. Rasmussen, S. Scherer, T. Zimmermann-Belsing, U. Feldt-Rasmussen, Thyrotropin-releasing hormone stimulation test in patients with pituitary pathology. Horm. Res. 61, 53–57 (2004)PubMed M.L. Hartoft-Nielsen, M. Lange, A.K. Rasmussen, S. Scherer, T. Zimmermann-Belsing, U. Feldt-Rasmussen, Thyrotropin-releasing hormone stimulation test in patients with pituitary pathology. Horm. Res. 61, 53–57 (2004)PubMed
59.
go back to reference B. Biondi, D.S. Cooper, Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid 20, 135–146 (2010)CrossRef B. Biondi, D.S. Cooper, Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid 20, 135–146 (2010)CrossRef
60.
go back to reference G.A. Brent, Mechanisms of thyroid hormone action. J. Clin. Invest. 122, 3035–3043 (2012)CrossRef G.A. Brent, Mechanisms of thyroid hormone action. J. Clin. Invest. 122, 3035–3043 (2012)CrossRef
61.
go back to reference C. Perez-Castro, U. Renner, M.R. Haedo, G.K. Stalla, E. Arzt, Cellular and molecular specificity of pituitary gland physiology. Physiol. Rev. 92, 1–38 (2012)CrossRef C. Perez-Castro, U. Renner, M.R. Haedo, G.K. Stalla, E. Arzt, Cellular and molecular specificity of pituitary gland physiology. Physiol. Rev. 92, 1–38 (2012)CrossRef
62.
go back to reference V. Birzniece, K.K.Y. Ho, Sex steroids and the GH axis: Implications for the management of hypopituitarism. Best. Pract. Res. Clin. Endocrinol. Metab. 31, 59–69 (2017)CrossRef V. Birzniece, K.K.Y. Ho, Sex steroids and the GH axis: Implications for the management of hypopituitarism. Best. Pract. Res. Clin. Endocrinol. Metab. 31, 59–69 (2017)CrossRef
63.
go back to reference J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi, D.S. Cooper, B.W. Kim, R.P. Peeters, M.S. Rosenthal, A.M. Sawka, Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 24, 1670–1751 (2014)CrossRef J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi, D.S. Cooper, B.W. Kim, R.P. Peeters, M.S. Rosenthal, A.M. Sawka, Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 24, 1670–1751 (2014)CrossRef
64.
go back to reference S. Benvenga, G. Capodicasa, S. Perelli, l-Thyroxine in an oral liquid or softgel formulation ensures more normal serum levels of free T4 in patients with central hypothyroidism. Front Endocrinol. 8, 321 (2017)CrossRef S. Benvenga, G. Capodicasa, S. Perelli, l-Thyroxine in an oral liquid or softgel formulation ensures more normal serum levels of free T4 in patients with central hypothyroidism. Front Endocrinol. 8, 321 (2017)CrossRef
65.
go back to reference S. Benvenga, When thyroid hormone replacement is ineffective? Curr. Opin. Endocrinol. Diabetes Obes. 20, 467–477 (2013)CrossRef S. Benvenga, When thyroid hormone replacement is ineffective? Curr. Opin. Endocrinol. Diabetes Obes. 20, 467–477 (2013)CrossRef
66.
go back to reference M.A. Garmendia, P.S. Santos, F. Guillen-Grima, J.C. Galofre, The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J. Clin. Endocrinol. Metab. 99, 923–931 (2014)CrossRef M.A. Garmendia, P.S. Santos, F. Guillen-Grima, J.C. Galofre, The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J. Clin. Endocrinol. Metab. 99, 923–931 (2014)CrossRef
67.
go back to reference M. Regal, C. Paramo, S.M. Sierra, R.V. Garcia-Mayor, Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin. Endocrinol. 55, 735–740 (2001)CrossRef M. Regal, C. Paramo, S.M. Sierra, R.V. Garcia-Mayor, Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin. Endocrinol. 55, 735–740 (2001)CrossRef
68.
go back to reference D. Preiss, L. Todd, M. Panarelli, Diagnosing unsuspected hypopituitarism in adults from suggestive thyroid function test results. Ann. Clin. Biochem. 45, 70–75 (2008)CrossRef D. Preiss, L. Todd, M. Panarelli, Diagnosing unsuspected hypopituitarism in adults from suggestive thyroid function test results. Ann. Clin. Biochem. 45, 70–75 (2008)CrossRef
69.
go back to reference M. Livingston, P.J. Twomey, A. Basu, S. Smellie, J.W. Kane, A. Heald, Should free thyroxine go back into the routine thyroid profile? Exp. Clin. Endocrinol. Diabetes 123, 594–597 (2015)CrossRef M. Livingston, P.J. Twomey, A. Basu, S. Smellie, J.W. Kane, A. Heald, Should free thyroxine go back into the routine thyroid profile? Exp. Clin. Endocrinol. Diabetes 123, 594–597 (2015)CrossRef
70.
go back to reference C.M. Dayan, Interpretation of thyroid function tests. Lancet 357, 619–624 (2001)CrossRef C.M. Dayan, Interpretation of thyroid function tests. Lancet 357, 619–624 (2001)CrossRef
71.
go back to reference C.A. Wardle, W.D. Fraser, C.R. Squire, Pitfalls in the use of thyrotropin concentration as a first-line thyroid-function test. Lancet 357, 1013–1014 (2001)CrossRef C.A. Wardle, W.D. Fraser, C.R. Squire, Pitfalls in the use of thyrotropin concentration as a first-line thyroid-function test. Lancet 357, 1013–1014 (2001)CrossRef
72.
go back to reference M. Klose, B. Jonsson, R. Abs, V. Popovic, M. Koltowska-Haggstrom, B. Saller, U. Feldt-Rasmussen, I. Kourides, From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis. Eur. J. Endocrinol. 161 Suppl 1, S75–S83 (2009)CrossRef M. Klose, B. Jonsson, R. Abs, V. Popovic, M. Koltowska-Haggstrom, B. Saller, U. Feldt-Rasmussen, I. Kourides, From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis. Eur. J. Endocrinol. 161 Suppl 1, S75–S83 (2009)CrossRef
Metadata
Title
Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions
Authors
Ulla Feldt-Rasmussen
Marianne Klose
Salvatore Benvenga
Publication date
01-12-2018
Publisher
Springer US
Published in
Endocrine / Issue 3/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1738-6

Other articles of this Issue 3/2018

Endocrine 3/2018 Go to the issue